Latest Form S-1 Stories
SANTA MONICA, Calif., May 19, 2014 /PRNewswire/ -- Kite Pharma, Inc., a clinical-stage biopharmaceutical company focused on developing engineered autologous T cell therapy (eACT(TM)) products
SANTA CLARA, Calif., May 1, 2014 /PRNewswire/ -- ProteinSimple announced today that it has filed a registration statement on Form S-1 with the Securities and Exchange Commission relating to
HOUSTON, April 29, 2014 /PRNewswire/ -- Westlake Chemical Corporation ("Westlake") (NYSE: WLK) announced today that one of its wholly owned subsidiaries, Westlake Chemical Partners LP ("Chemical
NORTHBOROUGH, Mass., April 28, 2014 /PRNewswire/ -- Aspen Aerogels, Inc.
GREENWOOD VILLAGE, Colo., April 21, 2014 /PRNewswire/ -- Ampio Pharmaceuticals Inc.
SOUTHLAKE, Texas, April 16, 2014 /PRNewswire/ -- Sabre Corporation ("Sabre"), a leading technology solutions provider to the global travel and tourism industry, today announced that it has priced
BASKING RIDGE, N.J., April 16, 2014 /PRNewswire/ -- Regado Biosciences, Inc. (Nasdaq: RGDO), today announced the closing of its previously announced underwritten public offering.
SANTA MONICA, Calif., April 4, 2014 /PRNewswire/ -- TrueCar today announced that it has filed a registration statement on Form
RICHMOND, Va., March 31, 2014 /PRNewswire/ -- Dominion Resources, Inc.